Do you want to read an article? Please log in or register.
Activating KRAS mutations mark premalignant cystic structures in congenital pulmonary airway malformations
Lung Cancer
Related content
Pulmonary Hypertension
Sports and Supervised Exercise Programmes for Children and Young Adults with Pulmonary Hypertension. 2026 Consensus Statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN) and the Association for European Paediatric and Congenital Cardiology (AEPC)
J Heart Lung Transplant
Dorobantu DM, van de Bruaene A, Budts W, Cifra B, Friedberg MK, Fritsch P, Khoury M, Müller J, Opotowsky A, Sanatani S, Williams C, Hansmann G, Pieles GE
doi: 10.1016/j.healun.2026.07.026
Pulmonary Fibrosis
Rescue of the CFTR chloride channel with nonsense mutations is markedly improved under inflammatory conditions
Eur Respir J
Borrelli A, Venturini A, Guidone D, De Santis M, Montemitro E, Alghisi F, Ciciriello F, Galietta LJV
doi: 10.1183/13993003.01171-2025
Lung Cancer
Pattern of brain metastases and survival in lung adenocarcinoma with KRAS or EFGR mutation
Lung Cancer
Faehling M, Fallscheer S, Schmiederer J, Sträter J, Christopoulos P, Lengerke C, Seifarth H
doi: 10.1016/j.lungcan.2025.108803
Lung Cancer
An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression
Nat Commun
Zhang Y, Fei Q, Li Y, Wang S, Rong T, Wu X, Gao H, Chen C, Gao D, Zhao Y, Li G, Chu H, Li W, Yang W
doi: 10.1038/s41467-026-68699-4
RECOMMENDED
Pulmonary Fibrosis
Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
Am J Respir Crit Care Med
Gramegna A, Putti G, Alicandro G, Mall MA, Blasi F
doi: 10.1093/ajrccm/aamag370
Lung Cancer
KRAS G12C Mutation Predicts Improved Survival in NSCLC Patients Receiving Immunotherapy: Insights from a Real-World Cohort
J Clin Med
Geçgel A, Şahin Çelik B, Peker P, Gökdere ZS, Koca D, Karaca B, Nart D, Göker E
doi: 10.3390/jcm14196826
RECOMMENDED
Asthma
Impact of benralizumab on airway structure/function in severe eosinophilic asthma
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res
Carstens DD, De Backer W, Rhodes K, Muchmore P, Lavon BR, Chung SYE, Fogel R, Trudo F, Panettieri R Jr
doi: 10.1186/s12931-026-03742-y
RECOMMENDED
Pulmonary Hypertension
Impact of elevated Pulmonary Arterial Wedge Pressure on safety and efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
Chest
Szwed P, Kurzyna P, Banaszkiewicz-Cyganik M, Kędzierski P, Łomiak M, Wolański R, Wasilewski M, Florczyk M, Piłka M, Torbicki A, Kurzyna M, Darocha S
doi: 10.1016/j.chest.2025.10.017
Pulmonary Fibrosis
Medication adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: Analysis on the French cystic fibrosis population from 2012-2020
Respir Med
Eid E, Payet C, Fernandez V, Belhassen M, Bessou A, Durieu I, Reynaud Q, Viprey M, French Cystic Fibrosis Centers Network, Cinthia R, Françoise T, Marie-Laure D, Bénédicte RT, Stéphanie B, Julie M, Murie L, Sylvie M, Ralph E, Frédéric H, Manuela S, Laurent M, Rébecca H, Catherine L, Camille A, Nathalie WD, Jane L, Philippe R, Jean-Christophe D, Martine RG, Raphaël C, Aurélie T, Anne G, Isabelle DB, Tiphaine B, Sylvie L, Pierre-Régis B, Isabelle S, Véronique H, Harriet C, Katia BK, Chantal B, Eric D, Sophie R, Christophe M, Nathalie A, Caroline P, Benjamin RP, Laurence W, Dominique G, Léa R, Marlène ME, Julie M, Laure C, Baptiste A, Gabsi Asma
doi: 10.1016/j.rmed.2026.108857